We are live on
!
Find out more
AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
33 hedge funds and large institutions have $28.5M invested in Agile Therapeutics in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
38% more funds holding
Funds holding: 24 → 33 (+9)
7% more capital invested
Capital invested by funds: $26.7M → $28.5M (+$1.84M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
33
Holders Change
+9
Holders Change %
+37.5%
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
6
Reduced
3
Closed
5
Calls
$61K
Puts
–
Net Calls
+$61K
Net Calls Change
-$156K
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$2.83M |
| 2 |
DM
Deerfield Management
New York
|
+$1.96M |
| 3 |
EP
Eversept Partners
New York
|
+$1.12M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$727K |
| 5 |
6CM
683 Capital Management
New York
|
+$463K |
Top Sellers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$2.21M |
| 2 |
FI
Fosun International
Hong Kong,
China
|
-$580K |
| 3 |
JP Morgan Chase
New York
|
-$108K |
| 4 |
NIM
Needham Investment Management
New York
|
-$49.3K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$22.2K |
